|
Market Closed -
Other stock markets
|
Pre-market 14:24:10 | |||
| 151 USD | +1.19% |
|
150.6 | -0.27% |
| 03:25pm | Sector Update: Health Care Stocks Lean Lower Premarket Wednesday | MT |
| 01:27pm | Genmab, J&J Log Higher Q2 Sales for Blood Cancer Drug Darzalex | MT |
Johnson & Johnson reported earnings results for the fourth quarter ended January 01, 2023. For the fourth quarter, the company reported sales was USD 23,706 million compared to USD 24,804 million a year ago. Net income was USD 3,520 million compared to USD 4,736 million a year ago.
Diluted earnings per share from continuing operations was USD 1.33 compared to USD 1.77 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.66% | 363B | |
| +61.53% | 848B | |
| +33.05% | 627B | |
| +15.06% | 318B | |
| +9.18% | 299B | |
| +13.66% | 243B | |
| +16.12% | 225B | |
| +15.67% | 179B | |
| +2.47% | 167B | |
| +1.23% | 125B |
JOHNSON & JOHNSON 
